Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
Abstract Identifying comorbidities in polymyalgia rheumatica/giant cell arteritis (PMR/GCA) is crucial for patients’ outcomes. The present study aimed to evaluate the impact of the inflammatory process and glucocorticoid treatment on aortic arterial stiffness and body composition in PMR/GCA. 77 pati...
Guardado en:
Autores principales: | Amir Emamifar, Torkell Ellingsen, Anne Pernille Hermann, Søren Hess, Oke Gerke, Ziba Ahangarani Farahani, Per Syrak Hansen, Inger Marie Jensen Hansen, Peter Thye-Rønn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/317f1d68ee1a47c181f361d374893342 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Elvis Hysa, et al.
Publicado: (2020) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019) -
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Ciro Manzo, et al.
Publicado: (2021) -
Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo C, et al.
Publicado: (2016) -
Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
por: Brawer AE
Publicado: (2016)